Rothschild & Co Asset Management US’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
Other funds holding ZBH
LP
BIT
BFA
Rothschild & Co Asset Management US's ZBH Position: Q4 2016 in Review
Rothschild & Co Asset Management US sold out of Zimmer Biomet (ZBH) in Q4 2016, closing a stake of 6,874 shares — an estimated $868K sold.
Rothschild & Co Asset Management US first reported a position in ZBH in Q2 2013 and held it in 14 quarters. The position peaked at $25.4M in Q1 2015. 812 funds tracked by Wall St. Rank hold ZBH as of Q4 2016.
- Rothschild & Co Asset Management US reported no remaining Zimmer Biomet position as of Q4 2016 after selling out during the quarter.
- Rothschild & Co Asset Management US sold 6,874 Zimmer Biomet shares in Q4 2016, an estimated $868K.
- Rothschild & Co Asset Management US first reported a position in Zimmer Biomet in Q2 2013 and held it in 14 quarters.
- Rothschild & Co Asset Management US's Zimmer Biomet position peaked at $25.4M in Q1 2015.
- 812 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2016.
Based on Rothschild & Co Asset Management US's 13F filing for Q4 2016, filed 15 Feb 2017.